Graham Capital Management L.P. Purchases Shares of 5,490 LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Graham Capital Management L.P. acquired a new stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 5,490 shares of the medical instruments supplier's stock, valued at approximately $506,000.

A number of other large investors have also modified their holdings of LMAT. New York State Teachers Retirement System boosted its position in shares of LeMaitre Vascular by 1.2% during the 4th quarter. New York State Teachers Retirement System now owns 8,189 shares of the medical instruments supplier's stock worth $755,000 after purchasing an additional 100 shares in the last quarter. Flputnam Investment Management Co. increased its holdings in LeMaitre Vascular by 3.6% in the fourth quarter. Flputnam Investment Management Co. now owns 2,923 shares of the medical instruments supplier's stock valued at $269,000 after buying an additional 102 shares in the last quarter. Norden Group LLC lifted its position in shares of LeMaitre Vascular by 4.5% during the 4th quarter. Norden Group LLC now owns 2,371 shares of the medical instruments supplier's stock valued at $218,000 after acquiring an additional 103 shares during the period. Blue Barn Wealth LLC boosted its stake in shares of LeMaitre Vascular by 4.4% during the 4th quarter. Blue Barn Wealth LLC now owns 2,485 shares of the medical instruments supplier's stock worth $229,000 after acquiring an additional 104 shares in the last quarter. Finally, Shaker Investments LLC OH grew its holdings in shares of LeMaitre Vascular by 0.8% in the 4th quarter. Shaker Investments LLC OH now owns 13,948 shares of the medical instruments supplier's stock worth $1,285,000 after acquiring an additional 112 shares during the period. 84.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

LMAT has been the topic of several research reports. Lake Street Capital increased their price target on shares of LeMaitre Vascular from $105.00 to $110.00 and gave the company a "buy" rating in a research report on Friday, February 28th. Wells Fargo & Company assumed coverage on LeMaitre Vascular in a research report on Thursday, February 13th. They set an "equal weight" rating and a $95.00 price target for the company. Barrington Research lowered LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Finally, Oppenheimer downgraded shares of LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Five investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $98.14.

Insider Buying and Selling at LeMaitre Vascular

In related news, CEO George W. Lemaitre sold 4,399 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $85.10, for a total value of $374,354.90. Following the completion of the transaction, the chief executive officer now owns 1,827,003 shares in the company, valued at $155,477,955.30. The trade was a 0.24% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Trent G. Kamke sold 2,009 shares of the business's stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $82.12, for a total value of $164,979.08. Following the transaction, the insider now owns 5,564 shares of the company's stock, valued at $456,915.68. The trade was a 26.53% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 102,009 shares of company stock valued at $8,721,836 in the last 90 days. 9.50% of the stock is currently owned by company insiders.

LeMaitre Vascular Trading Down 1.5%

Shares of LMAT traded down $1.25 during midday trading on Wednesday, hitting $83.51. The stock had a trading volume of 14,519 shares, compared to its average volume of 164,753. The business has a 50-day simple moving average of $84.27 and a two-hundred day simple moving average of $92.91. LeMaitre Vascular, Inc. has a fifty-two week low of $71.42 and a fifty-two week high of $109.58. The firm has a market cap of $1.89 billion, a P/E ratio of 45.63, a price-to-earnings-growth ratio of 2.22 and a beta of 0.86.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 EPS for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.15%. The firm had revenue of $59.87 million during the quarter, compared to analysts' expectations of $57.61 million. During the same quarter last year, the firm earned $0.44 EPS. The business's revenue for the quarter was up 12.0% compared to the same quarter last year. On average, analysts expect that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current fiscal year.

LeMaitre Vascular Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 0.96%. The ex-dividend date of this dividend is Thursday, May 15th. LeMaitre Vascular's payout ratio is presently 40.40%.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.